Carbapenem-resistant organisms: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "== Background == * Mechanisms include decreased expression of porins, increased expression of efflux pumps, and carbapenemases == Management == === Novel Antibiotics ==..." |
(No difference)
|
Revision as of 12:14, 21 September 2020
Background
- Mechanisms include decreased expression of porins, increased expression of efflux pumps, and carbapenemases
Management
Novel Antibiotics
| Antibiotic | KPC | NDM | OXA-48 | CRPsA | CRAcB | Stenotrophomonas |
|---|---|---|---|---|---|---|
| aztreonam-avibactam | + | + | + | ± | – | + |
| cefiderocol | + | + | + | + | + | + |
| ceftazidime-avibactam | + | – | + | ± | – | – |
| ceftolozane-tazobactam | – | – | – | ± | – | ± |
| eravacycline | + | + | + | – | + | + |
| fosfomycin | ± | ± | ± | ± | – | – |
| imipenem-relebactam | + | – | ± | + | – | – |
| meropenem-vaborbactam | + | – | – | – | – | – |
| plazomicin | + | ± | + | ± | – | – |
| colistin | ± | ± | ± | ± | ± | ± |
| tigecycline | + | + | + | – | + | + |
